Anika M.S. Hartz, PhD

Affiliations: 
UK Sanders-Brown Center on Aging 
Google:
"Anika Hartz"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sziraki A, Zhong Y, Neltner AM, et al. (2023) A high-throughput single-cell RNA expression profiling method identifies human pericyte markers. Neuropathology and Applied Neurobiology. e12942
Hartz A, Schulz J, Sokola B, et al. (2018) CADD-16. DUAL PI3K/Akt INHIBITION TO OVERCOME THE P-gp/BCRP DRUG EFFLUX SYSTEM FOR IMPROVED DRUG DELIVERY IN GLIOBLASTOMA THERAPY Neuro-Oncology. 20
Hartz AM, Pekcec A, Soldner EL, et al. (2017) P-gp protein expression and transport activity in rodent seizure models and human epilepsy. Molecular Pharmaceutics
Małecki A, Skipor-Lahuta J, Toborek M, et al. (2017) Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers Fluids and Barriers of the Cns. 14
Rempe RG, Hartz AM, Bauer B. (2016) Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Hartz AM, Zhong Y, Wolf A, et al. (2016) Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 1930-41
Akkaya BG, Zolnerciks JK, Ritchie TK, et al. (2015) The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1. Molecular Membrane Biology. 1-7
Jacob A, Hartz AM, Potin S, et al. (2011) Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels. Fluids and Barriers of the Cns. 8: 23
Agarwal S, Hartz AM, Elmquist WF, et al. (2011) Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. Current Pharmaceutical Design. 17: 2793-802
Shukla S, Skoumbourdis AP, Walsh MJ, et al. (2011) Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters. Molecular Pharmaceutics. 8: 1292-302
See more...